IL-1β inhibition in autoimmune inner ear disease: Can you hear me now?

5Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Clinical vignette: A 51-year-old man with right-sided sudden hearing loss presents to the otology clinic. He has a 4-year history of episodic vertigo of several hours' duration and fluctuating, progressive sensorineural hearing loss in his left ear. The vertigo attacks have not occurred for the last 18 months, and the left ear hearing is consistently poor. The patient's right ear hearing has dropped in the last 36 hours. MRI imaging of brain and temporal bone are normal. A 2-week "burst and taper" of oral prednisone is administered with no effect. Over the next 3 months, serial audiograms show rapidly progressive loss of threshold and word recognition scores on the right side. A trial of high-dose prednisone (60 mg/d for 30 days) results in full recovery of the right ear hearing and substantial improvement in the left ear. As the prednisone dose is slowly tapered over several months, the hearing drops again.

Cite

CITATION STYLE

APA

Rauch, S. D. (2014, September 2). IL-1β inhibition in autoimmune inner ear disease: Can you hear me now? Journal of Clinical Investigation. American Society for Clinical Investigation. https://doi.org/10.1172/JCI77197

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free